Roche, Syapse in precision medicine deal

Roche (SIX:ROG; OTCQX:RHHBY) partnered with precision medicine company Syapse (San Francisco, Calif.) to explore using AI and machine-learning to develop technology aimed at increasing patient access to precision medicines. The companies intend to create several products for users including oncologists, healthcare systems and payers.

Roche will fund product development under the multi-year deal and Syapse will develop the products with plans to use machine learning and AI. A Syapse spokesperson told BioCentury that rights to IP will be shared jointly, but Syapse will have exclusive rights to the technology. Syapse declined to disclose financial details...